Fitbit, Inc. (NYSE:FIT) today reported revenue of $272 million, GAAP net
loss per share of $(0.31), non-GAAP net loss per share of $(0.15), GAAP
net loss of $(79) million, non-GAAP net loss of $(38) million, cash flow
from operations of $(68) million and free cash flow of $(74) million for
its first quarter of 2019.
“We saw continued momentum across our business in the first quarter,
with revenue up 10% and devices sold up 36% year-over-year. Smartwatch
device sales increased 117% year-over-year and the introduction of our
new trackers, Inspire and Inspire HR, helped spark the first quarter of
year-over-year growth in tracker device sales in three years. In
addition, our Fitbit Health Solutions business grew 70% with revenue of
$30.5 million, demonstrating great progress towards our $100 million
revenue target for 2019,” said James Park, co-founder and CEO. “New
users are continuing to join the Fitbit platform with active users
increasing in the first quarter, underscoring the effectiveness of our
strategy to bring more users onto the Fitbit platform with the
introduction of more accessible, affordable devices.”
First Quarter 2019 |
||||||||
For the Three Months Ended | ||||||||
In millions, except percentages and per share amounts | March 30, 2019 | March 31, 2018 | ||||||
GAAP Results | ||||||||
Revenue | $ | 271.9 | $ | 247.9 | ||||
Gross Margin | 32.9 | % | 46.0 | % | ||||
Net Loss | $ | (79.5 | ) | $ | (80.9 | ) | ||
Net Loss Per Share | $ | (0.31 | ) | $ | (0.34 | ) | ||
Non-GAAP Results | ||||||||
Gross Margin | 34.2 | % | 47.1 | % | ||||
Net Loss | $ | (38.1 | ) | $ | (41.0 | ) | ||
Net Loss Per Share | $ | (0.15 | ) | $ | (0.17 | ) | ||
Adjusted EBITDA | $ | (43.2 | ) | $ | (46.2 | ) | ||
Devices Sold | 2.9 | 2.2 | ||||||
For additional information regarding the non-GAAP financial measures, see “Non-GAAP Financial Measures” and “Reconciliation of GAAP to Non-GAAP Financial Measures” below. Please note that certain terms used here, including “active user,” “activations,” and “repeat users,” are defined in our Annual Report on Form 10-K for the full year ended December 31, 2018 and the most recently filed Quarterly Report on Form 10-Q. |
First Quarter 2019 Financial Highlights
-
Devices sold increased 36% year-over-year to 2.9 million. Average
selling price decreased 19% year-over-year to $91 per device due to
the introduction of more affordable devices, lowering the barriers to
joining our community of active users. -
U.S. revenue represented 50% of total revenue or $135 million, down 3%
year-over-year. -
International revenue represented 50% of total revenue and grew 26% to
$137 million: EMEA revenue grew 35% to $87 million; APAC revenue grew
24% to $34 million and Americas excluding U.S. revenue declined 5% to
$15 million (all on a year-over-year basis). -
New devices introduced in the past 12 months, Fitbit Charge 3™, Fitbit
Inspire™, Fitbit Inspire HR™ and Fitbit Versa Lite Edition™,
represented 67% of revenue. -
GAAP gross margin was 32.9% and non-GAAP gross margin was 34.2%. Both
GAAP and non-GAAP gross margin were negatively impacted by the growing
mix of smartwatch revenue and lower yields from our product launch. -
GAAP operating expenses represented 63.4% of revenue, declining 12.6%
year-over-year to $172 million, and non-GAAP operating expenses
represented 55.4% of revenue, declining 13.1% to $151 million. -
A $2.5 million severance charge related to the restructuring of our
business further impacted GAAP operating expenses.
First Quarter 2019 Operational Highlights
-
Smartwatch devices sold increased 117% year-over-year and represented
42% of revenue. Trackers sold increased 17% year-over-year, reversing
a multi-year decline, and represented 58% of revenue. -
Strategy to increase affordability of our devices and grow our
community of active users is working with growth in active users in
the first quarter of 2019 on a year-over-year basis. -
Exited the first quarter of 2019 with a relatively clean retail
channel. -
Fitbit Health Solutions grew 70% year-over-year, with strength
overseas, and is on-track to deliver its full-year revenue target of
approximately $100 million. -
39% of activations came from repeat users; of the repeat users, 53%
came from users who were inactive for 90 days or more.
Second Quarter 2019 Guidance
-
We expect an increase in devices sold and a decline in average selling
price, each year-over-year. We expect revenue to grow 2% to 7%
year-over-year and to be in the range of $305 million to $320 million. - We expect non-GAAP gross margin to be approximately 36% to 38%.
-
We expect operating expenses to decline year-over-year, but to be
materially higher than in the first quarter of 2019 due to higher
sales and marketing expenses to support recent product introductions. -
We expect non-GAAP basic net loss per share in the range of $(0.20) to
$(0.17). -
We expect adjusted EBITDA to be in the range of a loss of $(59)
million to $(47) million. - Non-GAAP effective tax rate of approximately 25%.
-
Stock-based compensation expense of approximately $21 million and
basic share count of approximately 258 million. -
We expect capital expenditures as a percentage of revenue of
approximately 5% driven by the introduction of new products in the
first quarter.
Full Year 2019 Guidance
-
We expect devices sold to increase in 2019, but average selling price
to decline, each year-over-year driven by our intention to increase
accessibility to our platform and grow our community of active users.
We expect revenue to grow 1% to 4% year-over-year and to be in the
range of $1.52 billion to $1.58 billion. -
We expect non-GAAP gross margin to be approximately 41% in the second
half of the year and decline modestly to approximately 40% for the
full year. Second half gross margin will benefit from operating
leverage with higher revenue and improving yields. This will be
partially offset by lower warranty benefit in 2019 compared to 2018
and device mix shift towards smartwatches. As the size of our Fitbit
Health Solutions and software services business increases, we expect
them to be gross margin accretive to overall company gross margin. -
We expect to continue to drive operating leverage into the business
and are targeting operating expenses in the range of $660 million to
$690 million. -
We expect adjusted EBITDA to be in the range of $(30) million to
breakeven. -
Non-GAAP effective tax rate of approximately 30%. We expect non-GAAP
effective tax rate to be volatile driven by geographic mix of revenue,
tax credits, and our shift to profitability. -
Stock-based compensation expense of approximately $83 million and
basic and diluted share count of approximately 260 and 276 million,
respectively. - Capital expenditures as a percentage of revenue of approximately 3%.
-
With the year-over-year change in working capital anticipated to be
less of a benefit in 2019 as compared to 2018, we expect free cash
flow to be less than adjusted EBITDA, and in the range of
approximately $(40) million to $(70) million.
For additional information regarding the non-GAAP financial measures
presented above, see “Non-GAAP Financial Measures” below.
Webcast and Conference Call Information
Fitbit will host a conference call today at 5:00 p.m. Eastern Time, 2:00
p.m. Pacific Time, to discuss its results. Investors may access a live
webcast of the call through the Investor section of Fitbit’s website at
investor.fitbit.com. The call can also be accessed by dialing (888)
394-8218 or (646) 828-8193, access code 2305191. A replay of the call
will be archived on Fitbit’s website for the following six months.
Forward Looking Statements
This press release contains forward-looking statements that involve
risks and uncertainties, including statements regarding our outlook for
the second quarter of 2019 and full year 2019; product mix and
capabilities; trends in device sales, average selling price, revenue,
operating expenses, capital expenditures, free cash flow, gross margins,
non-GAAP net loss per share, stock-based compensation expense, adjusted
EBITDA, non-GAAP effective tax rate, and basic/diluted share count;
growth of our user base; growth in Fitbit Health Solutions and software
services and their impact on gross margins; and consumer and retail
demand for smartwatches and trackers. These forward-looking statements
are only predictions and may differ materially from actual results due
to a variety of factors, including: the effects of the highly
competitive market in which we operate, including competition from much
larger technology companies; our ability to anticipate and satisfy
consumer preferences in a timely manner; the market acceptance of our
smartwatches and their future potential; our ability to successfully
develop and timely introduce new products and services, including
recurring non-device revenue offerings, to enhance existing products and
services, and to engage and expand our user base; retail and customer
acceptance of existing and new products; our ability to accurately
forecast consumer demand and adequately manage our inventory; the impact
of changes in tax laws or the adoption of accounting pronouncements on
our operating results; our ability to timely ship products; our
reputation, brand awareness, and the overall market acceptance of our
products and services; our ability to achieve the objectives of
strategic and operational initiatives and to align our resources and
cost structure with business conditions; our ability to detect, prevent
or fix quality issues in our products or services; our reliance on
third-party suppliers, contract manufacturers, and logistics providers,
and our limited control over such parties; delays in procuring
components and product from these third parties or their suppliers; the
ability of third parties to successfully manufacture quality products
and ship in a timely manner; litigation and related costs; seasonality
of product sales; our ability to attract and retain employees; product
liability issues, security breaches, or other defects that may adversely
affect product performance; our ability to integrate acquired
technologies and the employees of acquired businesses into our
operations, particularly in new geographies; warranty claims; the fact
that the market for wearable devices is relatively new and unproven; the
ability of our channel partners to sell our products; privacy issues;
tariffs or other import restrictions; and other general market,
political, economic, and business conditions.
Additional risks and uncertainties that could affect our financial
results are included under the caption “Risk Factors” in our Annual
Report on Form 10-K for the full year ended December 31, 2018 and our
most recently filed Quarterly Report on Form 10-Q which are available on
our Investor Relations website at investor.fitbit.com and on
the SEC website at www.sec.gov.
Once filed with the SEC, additional information will also be set forth
in our Quarterly Report on Form 10-Q for the quarter ended March 30,
2019. All forward-looking statements contained herein are based on
information available to us as of the date hereof and we do not assume
any obligation to update these statements as a result of new information
or future events.
Disclosure of Material Information
Fitbit announces material information to its investors using SEC
filings, press releases, public conference calls and on its Investor
Relations page on the company’s website at http://investor.fitbit.com.
Non-GAAP Financial Measures
To supplement our consolidated financial statements, which are prepared
and presented in accordance with GAAP, we use the following non-GAAP
financial measures in this press release: non-GAAP gross profit,
non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating
loss, non-GAAP operating loss before income taxes, non-GAAP net loss,
non-GAAP basic/diluted net loss per share, non-GAAP free cash flow,
non-GAAP effective tax rate, non-GAAP research and development expenses,
non-GAAP sales and marketing expenses, non-GAAP general and
administrative expenses, and adjusted EBITDA. The presentation of these
financial measures is not intended to be considered in isolation or as a
substitute for, or superior to, financial information prepared and
presented in accordance with GAAP.
We use non-GAAP measures to internally evaluate and analyze financial
results. We believe these non-GAAP financial measures provide investors
with useful supplemental information about the financial performance of
our business, enable comparison of financial results between periods
where certain items may vary independent of business performance, and
enable comparison of our financial results with other public companies,
many of which present similar non-GAAP financial measures.
There are limitations associated with the use of non-GAAP financial
measures as an analytical tool. In particular, many of the adjustments
to our GAAP financial measures reflect the exclusion of certain items,
specifically stock-based compensation expense, depreciation,
amortization of intangible assets, interest income, net, and the related
income tax effects of the aforementioned exclusions, that are recurring
and will be reflected in our financial results for the foreseeable
future. In addition, these measures may be different from non-GAAP
financial measures used by other companies, limiting their usefulness
for comparison purposes. A reconciliation of our non-GAAP financial
measures to their most directly comparable GAAP measures has been
provided in the financial statement tables included in this press
release, and investors are encouraged to review the reconciliation.
Guidance for non-GAAP financial measures excludes stock-based
compensation, impact of restructuring, amortization of acquired
intangible assets, and tax effects associated with these items. We have
not reconciled guidance for non-GAAP financial measures to their most
directly comparable GAAP measures because certain items that impact
these measures are uncertain, out of our control, and/or cannot be
reasonably predicted. Accordingly, a reconciliation of the non-GAAP
financial measure guidance to the corresponding GAAP measures is not
available without unreasonable effort.
The following are explanations of the adjustments that are reflected in
one or more of our non-GAAP financial measures:
-
Stock-based compensation expense relates to equity awards granted
primarily to our employees. We exclude stock-based compensation
expense because we believe that the non-GAAP financial measures
excluding this item provide meaningful supplemental information
regarding operational performance. In particular, companies calculate
stock-based compensation expense using a variety of valuation
methodologies and subjective assumptions. -
Restructuring costs primarily included severance-related costs. We
believe that excluding this expense provides greater visibility to the
underlying performance of our business operations, facilitates
comparison of our results with other periods, and may also facilitate
comparison with the results of other companies in our industry. -
Litigation expense relates to legal costs incurred due to litigation
with Aliphcom, Inc. d/b/a Jawbone. We exclude these expenses because
we do not believe they have a direct correlation to the operations of
our business and because of the singular nature of the claims
underlying the Jawbone litigation matters. -
Amortization of intangible assets relates to our acquisitions of
FitStar, Pebble, Vector and Twine Health. We exclude these
amortization expenses because we do not believe they have a direct
correlation to the operation of our business. -
Income tax effect of non-GAAP adjustments relates to the tax effect of
the adjustments that we incorporate into non-GAAP financial measures
such as stock-based compensation, amortization of intangibles,
restructuring and valuation allowance in order to provide a more
meaningful measure of non-GAAP net loss. -
We define free cash flow as net cash provided by (used in) operating
activities less purchase of property and equipment. We consider free
cash flow to be a liquidity measure that provides useful information
to management and investors about the amount of cash generated by the
business that can possibly be used for investing in our business and
strengthening the balance sheet, but it is not intended to represent
the residual cash flow available for discretionary expenditures. Free
cash flow is not prepared in accordance with U.S. GAAP, and should not
be considered in isolation of, or as an alternative to, measures
prepared in accordance with U.S. GAAP.
About Fitbit, Inc. (NYSE: FIT)
Fitbit helps people lead healthier, more active lives by empowering them
with data, inspiration and guidance to reach their goals. Fitbit designs
products and experiences that track and provide motivation for everyday
health and fitness. Fitbit’s diverse line of innovative and popular
products include Fitbit Charge 3™, Fitbit Inspire HR™, Fitbit Inspire™,
and Fitbit Ace 2™ activity trackers, as well as the Fitbit Ionic™ and
Fitbit Versa™ family of smartwatches, Fitbit Flyer™ wireless headphones,
and Fitbit Aria 2™ Wi-Fi Smart Scale. Fitbit products are carried in
over 39,000 retail stores and in 87 countries around the globe. Powered
by one of the world’s largest health and fitness social networks and
databases of health and fitness data, the Fitbit platform delivers
personalized experiences, insights and guidance through leading software
and interactive tools, including the Fitbit and Fitbit Coach apps, and
Fitbit OS for smartwatches. Fitbit Health Solutions develops health and
wellness solutions designed to help increase engagement, improve health
outcomes, and drive a positive return for employers, health plans and
health systems.
Fitbit and the Fitbit logo are trademarks or registered trademarks
of Fitbit, Inc. in the U.S. and other countries. Additional Fitbit
trademarks can be found at www.fitbit.com/legal/trademark-list.
Third-party trademarks are the property of their respective owners.
Connect with us on Facebook, Instagram or Twitter and share
your Fitbit experience.
FITBIT, INC. | ||||||||
Condensed Consolidated Statements of Operations | ||||||||
(In thousands, except per share amounts) |
||||||||
(unaudited) |
||||||||
Three Months Ended | ||||||||
March 30, 2019 | March 31, 2018 | |||||||
Revenue | $ | 271,890 | $ | 247,865 | ||||
Cost of revenue | 182,437 | 133,742 | ||||||
Gross profit | 89,453 | 114,123 | ||||||
Operating expenses: | ||||||||
Research and development | 77,039 | 89,336 | ||||||
Sales and marketing | 68,616 | 72,052 | ||||||
General and administrative | 26,692 | 36,088 | ||||||
Total operating expenses | 172,347 | 197,476 | ||||||
Operating loss | (82,894 | ) | (83,353 | ) | ||||
Interest income, net | 3,466 | 1,350 | ||||||
Other income, net | 1,273 | 517 | ||||||
Loss before income taxes | (78,155 | ) | (81,486 | ) | ||||
Income tax expense (benefit) | 1,310 | (609 | ) | |||||
Net loss | $ | (79,465 | ) | $ | (80,877 | ) | ||
Net loss per share: | ||||||||
Basic | $ | (0.31 | ) | $ | (0.34 | ) | ||
Diluted | $ | (0.31 | ) | $ | (0.34 | ) | ||
Shares used to compute net loss per share: | ||||||||
Basic | 253,124 | 239,431 | ||||||
Diluted | 253,124 | 239,431 |
FITBIT, INC. |
||||||||
Condensed Consolidated Balance Sheets |
||||||||
(In thousands) |
||||||||
(unaudited) |
||||||||
March 30, 2019 |
December 31, 2018 |
|||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 410,813 | $ | 473,956 | ||||
Marketable securities | 233,383 | 249,493 | ||||||
Accounts receivable, net | 250,582 | 414,209 | ||||||
Inventories | 174,478 | 124,871 | ||||||
Income tax receivable | 6,917 | 6,957 | ||||||
Prepaid expenses and other current assets | 26,481 | 42,325 | ||||||
Total current assets | 1,102,654 | 1,311,811 | ||||||
Property and equipment, net | 95,275 | 106,286 | ||||||
Operating lease right-of use-assets | 99,144 | — | ||||||
Goodwill | 60,979 | 60,979 | ||||||
Intangible assets, net | 21,559 | 23,620 | ||||||
Deferred tax assets | 4,436 | 4,489 | ||||||
Other assets | 10,423 | 8,362 | ||||||
Total assets | $ | 1,394,470 | $ | 1,515,547 | ||||
Liabilities and Stockholders’ Equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 165,551 | $ | 251,657 | ||||
Accrued liabilities | 363,751 | 437,234 | ||||||
Operating lease liabilities | 30,209 | — | ||||||
Deferred revenue | 28,655 | 29,400 | ||||||
Income taxes payable | 1,349 | 1,092 | ||||||
Total current liabilities | 589,515 | 719,383 | ||||||
Long-term deferred revenue | 5,922 | 7,436 | ||||||
Long-term operating lease liabilities | 98,219 | — | ||||||
Other liabilities | 29,001 | 52,790 | ||||||
Total liabilities | 722,657 | 779,609 | ||||||
Stockholders’ equity: | ||||||||
Class A and Class B common stock | 25 | 25 | ||||||
Additional paid-in capital | 1,070,224 | 1,055,046 | ||||||
Accumulated other comprehensive income (loss) | 96 | (66 | ) | |||||
Accumulated deficit | (398,532 | ) | (319,067 | ) | ||||
Total stockholders’ equity |
671,813 | 735,938 | ||||||
Total liabilities and stockholders’ equity | $ | 1,394,470 | $ | 1,515,547 | ||||
FITBIT, INC. | ||||||||
Condensed Consolidated Statements of Cash Flow | ||||||||
(In thousands) | ||||||||
(unaudited) | ||||||||
Three Months Ended | ||||||||
March 30, 2019 | March 31, 2018 | |||||||
Cash Flows from Operating Activities | ||||||||
Net loss | $ | (79,465 | ) | $ | (80,877 | ) | ||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
||||||||
Provision for doubtful accounts | 32 | — | ||||||
Provision for inventory obsolescence | 1,478 | 6,337 | ||||||
Depreciation | 13,373 | 10,456 | ||||||
Non-cash lease expense | 7,713 | — | ||||||
Write-off of property and equipment | — | 7,259 | ||||||
Amortization of intangible assets | 2,060 | 1,748 | ||||||
Stock-based compensation | 20,544 | 23,641 | ||||||
Deferred income taxes | (20 | ) | (1,799 | ) | ||||
Other | (50 | ) | (275 | ) | ||||
Changes in operating assets and liabilities, net of acquisition: | ||||||||
Accounts receivable | 163,592 | 191,982 | ||||||
Inventories | (50,958 | ) | (27,307 | ) | ||||
Prepaid expenses and other assets | 12,594 | 39,610 | ||||||
Fitbit force recall reserve | 46 | (132 | ) | |||||
Accounts payable | (81,656 | ) | (84,155 | ) | ||||
Accrued liabilities and other liabilities | (69,962 | ) | (70,147 | ) | ||||
Lease liabilities | (4,972 | ) | — | |||||
Deferred revenue | (2,259 | ) | (6,010 | ) | ||||
Income taxes payable | 257 | (173 | ) | |||||
Net cash provided by (used in) operating activities | (67,653 | ) | 10,158 | |||||
Cash Flows from Investing Activities | ||||||||
Purchase of property and equipment | (6,096 | ) | (12,616 | ) | ||||
Purchases of marketable securities | (111,615 | ) | (141,404 | ) | ||||
Sales of marketable securities | — | 50,795 | ||||||
Maturities of marketable securities | 128,309 | 148,041 | ||||||
Acquisition, net of cash acquired | — | (13,646 | ) | |||||
Net cash provided by investing activities | 10,598 | 31,170 | ||||||
Cash Flows from Financing Activities | ||||||||
Repayment of debt | — | (747 | ) | |||||
Financing lease | (597 | ) | — | |||||
Proceeds from issuance of common stock | 931 | 992 | ||||||
Taxes paid related to net share settlement of restricted stock units | (6,422 | ) | (5,179 | ) | ||||
Net cash used in financing activities | (6,088 | ) | (4,934 | ) | ||||
Net increase (decrease) in cash and cash equivalents | (63,143 | ) | 36,394 | |||||
Cash and cash equivalents at beginning of period | 473,956 | 341,966 | ||||||
Cash and cash equivalents at end of period | $ | 410,813 | $ | 378,360 | ||||
FITBIT, INC. | ||||||||
Reconciliation of GAAP to Non-GAAP Financial Measures | ||||||||
(In thousands, except percentages and per share amounts) | ||||||||
(unaudited) | ||||||||
Three Months Ended | ||||||||
March 30, 2019 | March 31, 2018 | |||||||
Non-GAAP gross profit: | ||||||||
GAAP gross profit | $ | 89,453 | $ | 114,123 | ||||
Stock-based compensation expense | 1,430 | 1,098 | ||||||
Impact of restructuring | 190 | — | ||||||
Intangible assets amortization | 1,854 | 1,516 | ||||||
Non-GAAP gross profit | $ | 92,927 | $ | 116,737 | ||||
Non-GAAP gross margin (as a percentage of revenue): | ||||||||
GAAP gross margin | 32.9 | % | 46.0 | % | ||||
Stock-based compensation expense | 0.5 | 0.4 | ||||||
Impact of restructuring | 0.1 | — | ||||||
Intangible assets amortization | 0.7 | 0.6 | ||||||
Non-GAAP gross margin | 34.2 | % | 47.1 | % | ||||
Non-GAAP research and development: | ||||||||
GAAP research and development | $ | 77,039 | $ | 89,336 | ||||
Stock-based compensation expense | (11,988 | ) | (14,671 | ) | ||||
Impact of restructuring | (1,550 | ) | — | |||||
Non-GAAP research and development | $ | 63,501 | $ | 74,665 | ||||
Non-GAAP sales and marketing expense: | ||||||||
GAAP sales and marketing | $ | 68,616 | $ | 72,052 | ||||
Stock-based compensation expense | (3,138 | ) | (3,447 | ) | ||||
Impact of restructuring | (589 | ) | — | |||||
Intangible assets amortization | (135 | ) | (161 | ) | ||||
Non-GAAP sales and marketing | $ | 64,754 | $ | 68,444 | ||||
Non-GAAP general and administrative expense: | ||||||||
GAAP general and administrative | $ | 26,692 | $ | 36,088 | ||||
Stock-based compensation expense | (3,988 | ) | (4,425 | ) | ||||
Litigation expense | — | (765 | ) | |||||
Impact of restructuring | (129 | ) | — | |||||
Intangible assets amortization | (71 | ) | (71 | ) | ||||
Non-GAAP general and administrative | $ | 22,504 | $ | 30,827 | ||||
Non-GAAP operating expenses: | ||||||||
GAAP operating expenses | $ | 172,347 | $ | 197,476 | ||||
Stock-based compensation expense | (19,114 | ) | (22,543 | ) | ||||
Litigation expense | — | (765 | ) | |||||
Impact of restructuring | (2,268 | ) | — | |||||
Intangible assets amortization | (206 | ) | (232 | ) | ||||
Non-GAAP operating expenses | $ | 150,759 | $ | 173,936 | ||||
FITBIT, INC. | ||||||||
Reconciliation of GAAP to Non-GAAP Financial Measures | ||||||||
(In thousands, except percentages and per share amounts) | ||||||||
(unaudited) | ||||||||
Three Months Ended | ||||||||
March 30, 2019 | March 31, 2018 | |||||||
Non-GAAP operating loss and loss before income taxes: | ||||||||
GAAP operating loss | $ | (82,894 | ) | $ | (83,353 | ) | ||
Stock-based compensation expense | 20,544 | 23,641 | ||||||
Litigation expense | — | 765 | ||||||
Impact of restructuring | 2,458 | — | ||||||
Intangible assets amortization | 2,060 | 1,748 | ||||||
Non-GAAP operating loss | (57,832 | ) | (57,199 | ) | ||||
Interest income, net | 3,466 | 1,350 | ||||||
Other income, net | 1,273 | 517 | ||||||
Non-GAAP loss before income taxes | $ | (53,093 | ) | $ | (55,332 | ) | ||
Non-GAAP net loss and net loss per share: | ||||||||
Net loss | $ | (79,465 | ) | $ | (80,877 | ) | ||
Stock-based compensation expense | 20,544 | 23,641 | ||||||
Litigation expense | — | 765 | ||||||
Impact of restructuring | 2,458 | — | ||||||
Intangible assets amortization | 2,060 | 1,748 | ||||||
Income tax effect of non-GAAP adjustments | 16,335 | 13,767 | ||||||
Non-GAAP net loss | $ | (38,068 | ) | $ | (40,956 | ) | ||
GAAP diluted shares | 253,124 | 239,431 | ||||||
Other dilutive equity awards | — | — | ||||||
Non-GAAP diluted shares | 253,124 | 239,431 | ||||||
Non-GAAP diluted net loss per share | $ | (0.15 | ) | $ | (0.17 | ) | ||
Free cash flow: | ||||||||
Net cash provided by (used in) operating activities | $ | (67,653 | ) | $ | 10,158 | |||
Purchases of property and equipment | (6,096 | ) | (12,616 | ) | ||||
Free cash flow | $ | (73,749 | ) | $ | (2,458 | ) | ||
Net cash provided by investing activities | $ | 10,598 | $ | 31,170 | ||||
Net cash used in financing activities | $ | (6,088 | ) | $ | (4,934 | ) | ||
FITBIT, INC. | ||||||||
Reconciliation of GAAP to Non-GAAP Financial Measures | ||||||||
(In thousands, except percentages and per share amounts) | ||||||||
(unaudited) | ||||||||
Three Months Ended | ||||||||
March 30, 2019 | March 31, 2018 | |||||||
Adjusted EBITDA: | ||||||||
Net loss | $ | (79,465 | ) | $ | (80,877 | ) | ||
Stock-based compensation expense | 20,544 | 23,641 | ||||||
Litigation expense | — | 765 | ||||||
Impact of restructuring | 2,458 | — | ||||||
Depreciation and intangible assets amortization | 15,433 | 12,204 | ||||||
Interest income, net | (3,466 | ) | (1,350 | ) | ||||
Income tax expense (benefit) | 1,310 | (609 | ) | |||||
Adjusted EBITDA | $ | (43,186 | ) | $ | (46,226 | ) | ||
Stock-based compensation expense: | ||||||||
Cost of revenue | $ | 1,430 | $ | 1,098 | ||||
Research and development | 11,988 | 14,671 | ||||||
Sales and marketing | 3,138 | 3,447 | ||||||
General and administrative | 3,988 | 4,425 | ||||||
Total stock-based compensation expense | $ | 20,544 | $ | 23,641 | ||||
FITBIT, INC. | |||||||
Revenue by Geographic Region | |||||||
(In thousands) | |||||||
(unaudited) | |||||||
Three Months Ended | |||||||
March 30, 2019 | March 31, 2018 | ||||||
United States | $ | 135,091 | $ | 139,496 | |||
Americas, excluding United States | 15,327 | 16,100 | |||||
Europe, Middle East, and Africa | 87,098 | 64,538 | |||||
APAC | 34,374 | 27,731 | |||||
Total | $ | 271,890 | $ | 247,865 | |||
View source version on businesswire.com: https://www.businesswire.com/news/home/20190501005817/en/